Statistics for the Plotted Points |
TERBUTHYLAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 99% | 10% | 98% | 9% |
Total | 44 | 99% | 10% | 98% | 9% |
Miscellaneous Statistics for the Samples |
TERBUTHYLAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Statistics for the Plotted Points |
HEXAZINONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 120% | 11% | 119% | 13% |
>= Reporting Level | 40 | 71% | 20% | 70% | 14% |
Total | 44 | 75% | 24% | 71% | 17% |
Miscellaneous Statistics for the Samples |
HEXAZINONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 7 | 16% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 86 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Statistics for the Plotted Points |
SIMAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 42 | 101% | 12% | 101% | 12% |
Total | 42 | 101% | 12% | 101% | 12% |
Miscellaneous Statistics for the Samples |
SIMAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 42 |
Not Spiked | 87 | . | |
False Positives | 20 | 23% | 20 out of 86 |
Statistics for the Plotted Points |
PROMETRYN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 194% | 10% | 200% | 11% |
>= Reporting Level | 40 | 97% | 14% | 95% | 12% |
Total | 46 | 110% | 36% | 101% | 14% |
Miscellaneous Statistics for the Samples |
PROMETRYN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 0 | 0% | 0 out of 46 |
Not Spiked | 84 | . | |
False Positives | 1 | 1% | 1 out of 82 |
Statistics for the Plotted Points |
PROMETON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 88% | 15% | 88% | 16% |
Total | 40 | 88% | 15% | 88% | 16% |
Miscellaneous Statistics for the Samples |
PROMETON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 88 | . | |
False Positives | 1 | 1% | 1 out of 88 |
Statistics for the Plotted Points |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 52% | 15% | 47% | 14% |
Total | 41 | 52% | 15% | 47% | 14% |
Miscellaneous Statistics for the Samples |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 41 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 88 | . | |
False Positives | 0 | 0% | 0 out of 87 |
Statistics for the Plotted Points |
CYANAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 126% | . | 126% | 0% |
>= Reporting Level | 53 | 88% | 19% | 91% | 17% |
Total | 54 | 89% | 20% | 92% | 18% |
Miscellaneous Statistics for the Samples |
CYANAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 54 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 56 | . | |
False Negatives | 0 | 0% | 0 out of 55 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 73 |
Statistics for the Plotted Points |
FONOFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 200% | 0% | 200% | 0% |
>= Reporting Level | 33 | 88% | 23% | 88% | 13% |
Total | 37 | 101% | 41% | 89% | 15% |
Miscellaneous Statistics for the Samples |
FONOFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 95% | Spiked |
Estimated Values | 4 | 10% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 5% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 91 | . | |
False Positives | 1 | 1% | 1 out of 89 |
Statistics for the Plotted Points |
ALPHA-ENDOSULFAN (ENDOSULFAN I) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 87% | 14% | 86% | 15% |
Total | 35 | 87% | 14% | 86% | 15% |
Miscellaneous Statistics for the Samples |
ALPHA-ENDOSULFAN (ENDOSULFAN I) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 94 | . | |
False Positives | 0 | 0% | 0 out of 93 |
Statistics for the Plotted Points |
DICROTOPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 10 | 40% | 12% | 40% | 11% |
>= Reporting Level | 29 | 18% | 7% | 17% | 5% |
Total | 39 | 24% | 13% | 19% | 12% |
Miscellaneous Statistics for the Samples |
DICROTOPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 91% | Spiked |
Estimated Values | 39 | 91% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 4 | 9% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Statistics for the Plotted Points |
DICHLOROVOS (DICHLORVOS) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 26% | 13% | 26% | 12% |
Total | 40 | 26% | 13% | 26% | 12% |
Miscellaneous Statistics for the Samples |
DICHLOROVOS (DICHLORVOS) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 98% | Spiked |
Estimated Values | 40 | 98% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 1 | 2% | 1 out of 41 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 87 |
Statistics for the Plotted Points |
CHLORPYRIFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 42 | 90% | 29% | 94% | 18% |
Total | 42 | 90% | 29% | 94% | 18% |
Miscellaneous Statistics for the Samples |
CHLORPYRIFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 100% | Spiked |
Estimated Values | 5 | 12% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 42 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 86 |
Statistics for the Plotted Points |
DIELDRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 38 | 97% | 15% | 95% | 15% |
Total | 38 | 97% | 15% | 95% | 15% |
Miscellaneous Statistics for the Samples |
DIELDRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 38 |
Not Spiked | 91 | . | |
False Positives | 0 | 0% | 0 out of 90 |
Statistics for the Plotted Points |
METOLACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 100% | 10% | 101% | 11% |
Total | 41 | 100% | 10% | 101% | 11% |
Miscellaneous Statistics for the Samples |
METOLACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 88 | . | |
False Positives | 0 | 0% | 0 out of 87 |
Statistics for the Plotted Points |
MALATHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 85% | . | 85% | 0% |
>= Reporting Level | 33 | 86% | 22% | 88% | 20% |
Total | 34 | 86% | 22% | 87% | 20% |
Miscellaneous Statistics for the Samples |
MALATHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 87% | Spiked |
Estimated Values | 2 | 5% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 5 | 13% | 5 out of 39 |
Not Spiked | 91 | . | |
False Positives | 0 | 0% | 0 out of 89 |
Statistics for the Plotted Points |
DIAZINON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 46 | 91% | 13% | 94% | 9% |
Total | 46 | 91% | 13% | 94% | 9% |
Miscellaneous Statistics for the Samples |
DIAZINON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 0 | 0% | 0 out of 46 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 82 |
Statistics for the Plotted Points |
ATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 99% | 10% | 100% | 8% |
Total | 41 | 99% | 10% | 100% | 8% |
Miscellaneous Statistics for the Samples |
ATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 88 | . | |
False Positives | 2 | 2% | 2 out of 87 |
Statistics for the Plotted Points |
ALACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 95% | 12% | 96% | 11% |
Total | 40 | 95% | 12% | 96% | 11% |
Miscellaneous Statistics for the Samples |
ALACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 88 |
Statistics for the Plotted Points |
ACETOCHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 199% | 2% | 200% | 0% |
>= Reporting Level | 40 | 102% | 12% | 103% | 11% |
Total | 46 | 115% | 35% | 105% | 13% |
Miscellaneous Statistics for the Samples |
ACETOCHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 100% | Spiked |
Estimated Values | 2 | 4% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 0 | 0% | 0 out of 46 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 82 |
Statistics for the Plotted Points |
1-NAPHTHOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 58% | 25% | 64% | 30% |
>= Reporting Level | 34 | 35% | 18% | 33% | 20% |
Total | 42 | 40% | 21% | 36% | 24% |
Miscellaneous Statistics for the Samples |
1-NAPHTHOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 98% | Spiked |
Estimated Values | 42 | 98% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 1 | 2% | 1 out of 43 |
Not Spiked | 87 | . | |
False Positives | 5 | 6% | 5 out of 85 |
Statistics for the Plotted Points |
CYFLUTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 70% | 15% | 66% | 9% |
>= Reporting Level | 35 | 60% | 19% | 58% | 19% |
Total | 40 | 61% | 18% | 59% | 17% |
Miscellaneous Statistics for the Samples |
CYFLUTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 40 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 89 | . | |
False Positives | 0 | 0% | 0 out of 88 |
Statistics for the Plotted Points |
CYPERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 62% | 5% | 62% | 5% |
>= Reporting Level | 42 | 62% | 15% | 61% | 12% |
Total | 44 | 62% | 15% | 61% | 12% |
Miscellaneous Statistics for the Samples |
CYPERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 44 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 86 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Statistics for the Plotted Points |
ENDOSULFAN SULFATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 94% | 17% | 92% | 14% |
Total | 34 | 94% | 17% | 92% | 14% |
Miscellaneous Statistics for the Samples |
ENDOSULFAN SULFATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 96 | . | |
False Positives | 0 | 0% | 0 out of 94 |
Statistics for the Plotted Points |
FENAMIPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 104% | 28% | 107% | 33% |
>= Reporting Level | 34 | 78% | 18% | 76% | 17% |
Total | 38 | 81% | 20% | 77% | 21% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 97% | Spiked |
Estimated Values | 4 | 10% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 89 |
Statistics for the Plotted Points |
IPRODIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 62% | 30% | 73% | 38% |
Total | 35 | 62% | 30% | 73% | 38% |
Miscellaneous Statistics for the Samples |
IPRODIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 95% | Spiked |
Estimated Values | 35 | 95% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 38 | . | |
False Negatives | 2 | 5% | 2 out of 37 |
Not Spiked | 92 | . | |
False Positives | 0 | 0% | 0 out of 90 |
Statistics for the Plotted Points |
ISOFENPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 93% | 18% | 95% | 24% |
Total | 41 | 93% | 18% | 95% | 24% |
Miscellaneous Statistics for the Samples |
ISOFENPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 87 |
Statistics for the Plotted Points |
CYHALOTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 86% | 10% | 87% | 12% |
>= Reporting Level | 30 | 44% | 15% | 45% | 18% |
Total | 34 | 49% | 20% | 47% | 21% |
Miscellaneous Statistics for the Samples |
CYHALOTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 97% | Spiked |
Estimated Values | 34 | 97% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 95 | . | |
False Positives | 0 | 0% | 0 out of 93 |
Statistics for the Plotted Points |
METALAXYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 93% | 13% | 94% | 11% |
Total | 39 | 93% | 13% | 94% | 11% |
Miscellaneous Statistics for the Samples |
METALAXYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 89 | . | |
False Positives | 0 | 0% | 0 out of 89 |
Statistics for the Plotted Points |
METHIDATHION (SUPRACIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 144% | 20% | 138% | 22% |
>= Reporting Level | 41 | 91% | 14% | 90% | 16% |
Total | 45 | 96% | 21% | 94% | 17% |
Miscellaneous Statistics for the Samples |
METHIDATHION (SUPRACIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 3 | 7% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 83 |
Statistics for the Plotted Points |
MYCLOBUTANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 97% | 13% | 91% | 17% |
>= Reporting Level | 34 | 88% | 17% | 87% | 21% |
Total | 37 | 88% | 16% | 88% | 18% |
Miscellaneous Statistics for the Samples |
MYCLOBUTANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 100% | Spiked |
Estimated Values | 5 | 14% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 37 | . | |
False Negatives | 0 | 0% | 0 out of 37 |
Not Spiked | 93 | . | |
False Positives | 0 | 0% | 0 out of 91 |
Statistics for the Plotted Points |
OXYFLUORFEN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 129% | 30% | 132% | 36% |
>= Reporting Level | 31 | 67% | 18% | 63% | 18% |
Total | 35 | 74% | 28% | 67% | 26% |
Miscellaneous Statistics for the Samples |
OXYFLUORFEN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 6 | 17% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 95 | . | |
False Positives | 0 | 0% | 0 out of 93 |
Statistics for the Plotted Points |
PHOSMET (IMIDAN) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 89% | 51% | 84% | 58% |
>= Reporting Level | 21 | 53% | 21% | 52% | 21% |
Total | 25 | 59% | 29% | 55% | 33% |
Miscellaneous Statistics for the Samples |
PHOSMET (IMIDAN) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 25 | 57% | Spiked |
Estimated Values | 25 | 57% | Spiked |
Deleted Values | 10 | 8% | Spiked + Not Spiked |
Spiked, Censored | 5 | 11% | Spiked |
Spiked | 45 | . | |
False Negatives | 14 | 32% | 14 out of 44 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 76 |
Statistics for the Plotted Points |
TEFLUTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 70% | 27% | 62% | 14% |
Total | 36 | 70% | 27% | 62% | 14% |
Miscellaneous Statistics for the Samples |
TEFLUTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 36 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 94 | . | |
False Positives | 0 | 0% | 0 out of 92 |
Statistics for the Plotted Points |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 69% | 4% | 69% | 6% |
>= Reporting Level | 29 | 67% | 17% | 67% | 16% |
Total | 33 | 67% | 16% | 67% | 15% |
Miscellaneous Statistics for the Samples |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 100% | Spiked |
Estimated Values | 33 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 33 |
Not Spiked | 97 | . | |
False Positives | 6 | 6% | 6 out of 95 |
Statistics for the Plotted Points |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 100% | 10% | 101% | 9% |
Total | 45 | 100% | 10% | 101% | 9% |
Miscellaneous Statistics for the Samples |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 83 |
Statistics for the Plotted Points |
2-ETHYL-6-METHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 118% | 14% | 117% | 18% |
>= Reporting Level | 28 | 90% | 8% | 91% | 8% |
Total | 32 | 94% | 13% | 92% | 10% |
Miscellaneous Statistics for the Samples |
2-ETHYL-6-METHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 32 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 97 | . | |
False Positives | 0 | 0% | 0 out of 96 |
Statistics for the Plotted Points |
3,4-DICHLOROANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 84% | 13% | 82% | 9% |
Total | 40 | 84% | 13% | 82% | 9% |
Miscellaneous Statistics for the Samples |
3,4-DICHLOROANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 40 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 88 |
Statistics for the Plotted Points |
3,5-DICHLOROANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 106% | 14% | 102% | 15% |
>= Reporting Level | 30 | 87% | 8% | 86% | 7% |
Total | 34 | 89% | 11% | 88% | 9% |
Miscellaneous Statistics for the Samples |
3,5-DICHLOROANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 100% | Spiked |
Estimated Values | 4 | 12% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 95 | . | |
False Positives | 2 | 2% | 2 out of 94 |
Statistics for the Plotted Points |
4-CHLORO-2-METHYLPHENOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 42 | 58% | 9% | 60% | 8% |
Total | 42 | 58% | 9% | 60% | 8% |
Miscellaneous Statistics for the Samples |
4-CHLORO-2-METHYLPHENOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 100% | Spiked |
Estimated Values | 42 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 42 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 86 |
Statistics for the Plotted Points |
AZINPHOS-METHYL-OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 41% | 12% | 36% | 11% |
>= Reporting Level | 24 | 54% | 27% | 45% | 25% |
Total | 28 | 52% | 26% | 42% | 22% |
Miscellaneous Statistics for the Samples |
AZINPHOS-METHYL-OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 100% | Spiked |
Estimated Values | 28 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 28 | . | |
False Negatives | 0 | 0% | 0 out of 28 |
Not Spiked | 102 | . | |
False Positives | 0 | 0% | 0 out of 100 |
Statistics for the Plotted Points |
CHLORPYRIFOS, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 38% | 15% | 43% | 13% |
>= Reporting Level | 31 | 26% | 13% | 24% | 12% |
Total | 36 | 28% | 14% | 25% | 14% |
Miscellaneous Statistics for the Samples |
CHLORPYRIFOS, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 84% | Spiked |
Estimated Values | 36 | 84% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 7% | Spiked |
Spiked | 43 | . | |
False Negatives | 4 | 9% | 4 out of 43 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Statistics for the Plotted Points |
DIAZINON, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 70% | 23% | 64% | 23% |
Total | 58 | 70% | 23% | 64% | 23% |
Miscellaneous Statistics for the Samples |
DIAZINON, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 88% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 68 | . | |
False Negatives | 7 | 11% | 7 out of 66 |
Not Spiked | 62 | . | |
False Positives | 1 | 2% | 1 out of 62 |
Statistics for the Plotted Points |
DISULFOTON SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 93% | 16% | 90% | 13% |
Total | 30 | 93% | 16% | 90% | 13% |
Miscellaneous Statistics for the Samples |
DISULFOTON SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 0 | 0% | 0 out of 30 |
Not Spiked | 100 | . | |
False Positives | 2 | 2% | 2 out of 98 |
Statistics for the Plotted Points |
ETHION MONOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 10 | 79% | 11% | 80% | 9% |
Total | 10 | 79% | 11% | 80% | 9% |
Miscellaneous Statistics for the Samples |
ETHION MONOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 10 | 100% | Spiked |
Estimated Values | 10 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 10 | . | |
False Negatives | 0 | 0% | 0 out of 10 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 118 |
Statistics for the Plotted Points |
FENAMIPHOS SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 82% | 27% | 79% | 35% |
>= Reporting Level | 35 | 67% | 21% | 64% | 25% |
Total | 43 | 70% | 23% | 64% | 25% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 100% | Spiked |
Estimated Values | 17 | 40% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Statistics for the Plotted Points |
FENAMIPHOS SULFOXIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 45% | 42% | 34% | 13% |
>= Reporting Level | 23 | 36% | 18% | 33% | 18% |
Total | 28 | 38% | 23% | 33% | 18% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS SULFOXIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 78% | Spiked |
Estimated Values | 28 | 78% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 5 | 14% | Spiked |
Spiked | 37 | . | |
False Negatives | 3 | 8% | 3 out of 36 |
Not Spiked | 93 | . | |
False Positives | 0 | 0% | 0 out of 91 |
Statistics for the Plotted Points |
MALAOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 109% | 24% | 116% | 35% |
>= Reporting Level | 38 | 79% | 24% | 81% | 20% |
Total | 41 | 82% | 25% | 83% | 18% |
Miscellaneous Statistics for the Samples |
MALAOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 95% | Spiked |
Estimated Values | 7 | 16% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 2 | 5% | 2 out of 43 |
Not Spiked | 87 | . | |
False Positives | 1 | 1% | 1 out of 85 |
Statistics for the Plotted Points |
PARAOXON-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 84% | . | 84% | 0% |
>= Reporting Level | 40 | 60% | 17% | 57% | 16% |
Total | 41 | 60% | 17% | 58% | 16% |
Miscellaneous Statistics for the Samples |
PARAOXON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 41 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 88 | . | |
False Positives | 0 | 0% | 0 out of 87 |
Statistics for the Plotted Points |
PHORATE OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 109% | 27% | 95% | 28% |
>= Reporting Level | 31 | 82% | 19% | 83% | 20% |
Total | 36 | 86% | 22% | 87% | 19% |
Miscellaneous Statistics for the Samples |
PHORATE OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 36 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 37 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 93 | . | |
False Positives | 0 | 0% | 0 out of 92 |
Statistics for the Plotted Points |
PHOSMET OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 40% | 24% | 36% | 25% |
>= Reporting Level | 12 | 61% | 41% | 51% | 45% |
Total | 18 | 54% | 37% | 45% | 42% |
Miscellaneous Statistics for the Samples |
PHOSMET OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 18 | 62% | Spiked |
Estimated Values | 18 | 62% | Spiked |
Deleted Values | 19 | 15% | Spiked + Not Spiked |
Spiked, Censored | 2 | 7% | Spiked |
Spiked | 31 | . | |
False Negatives | 9 | 31% | 9 out of 29 |
Not Spiked | 99 | . | |
False Positives | 0 | 0% | 0 out of 82 |
Statistics for the Plotted Points |
TERBUFOS-O-ANALOGUE SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 62% | . | 62% | 0% |
>= Reporting Level | 12 | 76% | 16% | 76% | 23% |
Total | 13 | 75% | 16% | 73% | 18% |
Miscellaneous Statistics for the Samples |
TERBUFOS-O-ANALOGUE SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 13 | 100% | Spiked |
Estimated Values | 6 | 46% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 13 | . | |
False Negatives | 0 | 0% | 0 out of 13 |
Not Spiked | 117 | . | |
False Positives | 0 | 0% | 0 out of 115 |
Statistics for the Plotted Points |
FIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 158% | 13% | 155% | 6% |
>= Reporting Level | 44 | 93% | 19% | 93% | 19% |
Total | 50 | 100% | 28% | 96% | 25% |
Miscellaneous Statistics for the Samples |
FIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 50 | 100% | Spiked |
Estimated Values | 50 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 50 | . | |
False Negatives | 0 | 0% | 0 out of 50 |
Not Spiked | 80 | . | |
False Positives | 5 | 6% | 5 out of 78 |
Statistics for the Plotted Points |
FIPRONIL SULFIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 93% | 17% | 91% | 15% |
Total | 36 | 93% | 17% | 91% | 15% |
Miscellaneous Statistics for the Samples |
FIPRONIL SULFIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 37 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 93 | . | |
False Positives | 17 | 18% | 17 out of 92 |
Statistics for the Plotted Points |
FIPRONIL SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 65% | 8% | 67% | 1% |
>= Reporting Level | 30 | 67% | 11% | 67% | 10% |
Total | 35 | 67% | 10% | 67% | 9% |
Miscellaneous Statistics for the Samples |
FIPRONIL SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 9 | 26% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 95 | . | |
False Positives | 17 | 18% | 17 out of 93 |
Statistics for the Plotted Points |
DESULFINYLFIPRONIL AMIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 10 | 76% | 25% | 81% | 21% |
Total | 10 | 76% | 25% | 81% | 21% |
Miscellaneous Statistics for the Samples |
DESULFINYLFIPRONIL AMIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 10 | 100% | Spiked |
Estimated Values | 10 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 10 | . | |
False Negatives | 0 | 0% | 0 out of 10 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 118 |
Statistics for the Plotted Points |
DESULFINYLFIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 23 | 87% | 16% | 85% | 20% |
Total | 23 | 87% | 16% | 85% | 20% |
Miscellaneous Statistics for the Samples |
DESULFINYLFIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 23 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 24 | . | |
False Negatives | 0 | 0% | 0 out of 23 |
Not Spiked | 106 | . | |
False Positives | 3 | 3% | 3 out of 105 |
Statistics for the Plotted Points |
TEBUCONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 87% | . | 87% | 0% |
>= Reporting Level | 52 | 50% | 13% | 49% | 13% |
Total | 53 | 51% | 14% | 49% | 13% |
Miscellaneous Statistics for the Samples |
TEBUCONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 98% | Spiked |
Estimated Values | 10 | 19% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 56 | . | |
False Negatives | 0 | 0% | 0 out of 54 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Statistics for the Plotted Points |
CIS-PROPICONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 96% | . | 96% | 0% |
>= Reporting Level | 9 | 103% | 12% | 103% | 12% |
Total | 10 | 102% | 11% | 102% | 13% |
Miscellaneous Statistics for the Samples |
CIS-PROPICONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 10 | 100% | Spiked |
Estimated Values | 10 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 10 | . | |
False Negatives | 0 | 0% | 0 out of 10 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 118 |
Statistics for the Plotted Points |
TRANS-PROPICONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 10 | 94% | 11% | 93% | 13% |
Total | 10 | 94% | 11% | 93% | 13% |
Miscellaneous Statistics for the Samples |
TRANS-PROPICONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 10 | 100% | Spiked |
Estimated Values | 10 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 10 | . | |
False Negatives | 0 | 0% | 0 out of 10 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 118 |
Statistics for the Plotted Points |
ETHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 92% | 16% | 91% | 14% |
Total | 44 | 92% | 16% | 91% | 14% |
Miscellaneous Statistics for the Samples |
ETHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 86 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Statistics for the Plotted Points |
METRIBUZIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 73% | 10% | 73% | 11% |
Total | 45 | 73% | 10% | 73% | 11% |
Miscellaneous Statistics for the Samples |
METRIBUZIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 83 |
Statistics for the Plotted Points |
2,6-DIETHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 99% | 12% | 99% | 9% |
Total | 40 | 99% | 12% | 99% | 9% |
Miscellaneous Statistics for the Samples |
2,6-DIETHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 88 | . | |
False Positives | 0 | 0% | 0 out of 87 |
Statistics for the Plotted Points |
TRIFLURALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 111% | . | 111% | 0% |
>= Reporting Level | 37 | 78% | 14% | 78% | 13% |
Total | 38 | 79% | 15% | 79% | 15% |
Miscellaneous Statistics for the Samples |
TRIFLURALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 100% | Spiked |
Estimated Values | 3 | 8% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 38 |
Not Spiked | 91 | . | |
False Positives | 0 | 0% | 0 out of 90 |
Statistics for the Plotted Points |
DIMETHOATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 35% | 11% | 32% | 8% |
Total | 41 | 35% | 11% | 32% | 8% |
Miscellaneous Statistics for the Samples |
DIMETHOATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 41 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 88 | . | |
False Positives | 0 | 0% | 0 out of 87 |
Statistics for the Plotted Points |
PHORATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 83% | 5% | 86% | 6% |
>= Reporting Level | 32 | 70% | 14% | 69% | 15% |
Total | 37 | 72% | 14% | 73% | 15% |
Miscellaneous Statistics for the Samples |
PHORATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 100% | Spiked |
Estimated Values | 9 | 24% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 37 | . | |
False Negatives | 0 | 0% | 0 out of 37 |
Not Spiked | 93 | . | |
False Positives | 0 | 0% | 0 out of 91 |
Statistics for the Plotted Points |
PARATHION-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 177% | 21% | 177% | 32% |
>= Reporting Level | 33 | 78% | 20% | 75% | 16% |
Total | 39 | 93% | 41% | 77% | 22% |
Miscellaneous Statistics for the Samples |
PARATHION-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 100% | Spiked |
Estimated Values | 7 | 18% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 91 | . | |
False Positives | 0 | 0% | 0 out of 89 |
Statistics for the Plotted Points |
EPTC |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 56 | 99% | 13% | 99% | 9% |
Total | 56 | 99% | 13% | 99% | 9% |
Miscellaneous Statistics for the Samples |
EPTC |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 57 | . | |
False Negatives | 0 | 0% | 0 out of 56 |
Not Spiked | 73 | . | |
False Positives | 5 | 7% | 5 out of 72 |
Statistics for the Plotted Points |
TEBUTHIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 120% | 28% | 116% | 27% |
Total | 45 | 120% | 28% | 116% | 27% |
Miscellaneous Statistics for the Samples |
TEBUTHIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 83 |
Statistics for the Plotted Points |
MOLINATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 116% | 34% | 106% | 11% |
Total | 32 | 116% | 34% | 106% | 11% |
Miscellaneous Statistics for the Samples |
MOLINATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 89% | Spiked |
Estimated Values | 5 | 14% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 8% | Spiked |
Spiked | 36 | . | |
False Negatives | 1 | 3% | 1 out of 36 |
Not Spiked | 94 | . | |
False Positives | 0 | 0% | 0 out of 92 |
Statistics for the Plotted Points |
ETHOPROPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 143% | 53% | 161% | 41% |
>= Reporting Level | 50 | 102% | 17% | 102% | 18% |
Total | 55 | 106% | 25% | 108% | 19% |
Miscellaneous Statistics for the Samples |
ETHOPROPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 55 | 100% | Spiked |
Estimated Values | 5 | 9% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 57 | . | |
False Negatives | 0 | 0% | 0 out of 55 |
Not Spiked | 73 | . | |
False Positives | 0 | 0% | 0 out of 73 |
Statistics for the Plotted Points |
BENFLURALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 76% | 12% | 75% | 12% |
Total | 39 | 76% | 12% | 75% | 12% |
Miscellaneous Statistics for the Samples |
BENFLURALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 100% | Spiked |
Estimated Values | 6 | 15% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 89 |
Statistics for the Plotted Points |
CARBOFURAN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 84% | . | 84% | 0% |
>= Reporting Level | 34 | 96% | 18% | 95% | 18% |
Total | 35 | 95% | 18% | 94% | 18% |
Miscellaneous Statistics for the Samples |
CARBOFURAN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 35 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 95 | . | |
False Positives | 0 | 0% | 0 out of 93 |
Statistics for the Plotted Points |
TERBUFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 122% | 34% | 122% | 36% |
>= Reporting Level | 36 | 84% | 29% | 86% | 28% |
Total | 38 | 86% | 30% | 87% | 28% |
Miscellaneous Statistics for the Samples |
TERBUFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 95% | Spiked |
Estimated Values | 5 | 13% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 5% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 88 |
Statistics for the Plotted Points |
PROPYZAMIDE (PRONAMIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 103% | 20% | 101% | 17% |
Total | 40 | 103% | 20% | 101% | 17% |
Miscellaneous Statistics for the Samples |
PROPYZAMIDE (PRONAMIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 88 |
Statistics for the Plotted Points |
DISULFOTON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 52 | 67% | 16% | 66% | 18% |
Total | 52 | 67% | 16% | 66% | 18% |
Miscellaneous Statistics for the Samples |
DISULFOTON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 52 | 96% | Spiked |
Estimated Values | 52 | 96% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 4% | Spiked |
Spiked | 55 | . | |
False Negatives | 0 | 0% | 0 out of 54 |
Not Spiked | 75 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Statistics for the Plotted Points |
PROPANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 106% | 18% | 102% | 19% |
Total | 34 | 106% | 18% | 102% | 19% |
Miscellaneous Statistics for the Samples |
PROPANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 95 | . | |
False Positives | 0 | 0% | 0 out of 94 |
Statistics for the Plotted Points |
CARBARYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 14 | 98% | 19% | 104% | 19% |
>= Reporting Level | 25 | 83% | 32% | 82% | 25% |
Total | 39 | 88% | 29% | 88% | 30% |
Miscellaneous Statistics for the Samples |
CARBARYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 100% | Spiked |
Estimated Values | 39 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 89 |
Statistics for the Plotted Points |
THIOBENCARB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 175% | 19% | 175% | 20% |
>= Reporting Level | 31 | 105% | 15% | 105% | 17% |
Total | 33 | 109% | 23% | 105% | 18% |
Miscellaneous Statistics for the Samples |
THIOBENCARB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 94% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 6% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 94 | . | |
False Positives | 0 | 0% | 0 out of 93 |
Statistics for the Plotted Points |
DACTHAL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 196% | 10% | 200% | 0% |
>= Reporting Level | 34 | 122% | 32% | 110% | 21% |
Total | 40 | 133% | 40% | 112% | 54% |
Miscellaneous Statistics for the Samples |
DACTHAL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 13 | 33% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 88 |
Statistics for the Plotted Points |
PENDIMETHALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 94% | 16% | 91% | 17% |
Total | 45 | 94% | 16% | 91% | 17% |
Miscellaneous Statistics for the Samples |
PENDIMETHALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 83 |
Statistics for the Plotted Points |
PROPARGITE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 7 | 110% | 14% | 113% | 21% |
>= Reporting Level | 46 | 80% | 20% | 83% | 16% |
Total | 53 | 84% | 22% | 85% | 18% |
Miscellaneous Statistics for the Samples |
PROPARGITE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 98% | Spiked |
Estimated Values | 11 | 20% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 55 | . | |
False Negatives | 0 | 0% | 0 out of 54 |
Not Spiked | 75 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Statistics for the Plotted Points |
AZINPHOS-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 14 | 88% | 19% | 91% | 20% |
>= Reporting Level | 29 | 75% | 15% | 74% | 17% |
Total | 43 | 79% | 18% | 79% | 19% |
Miscellaneous Statistics for the Samples |
AZINPHOS-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 100% | Spiked |
Estimated Values | 43 | 100% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 87 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Statistics for the Plotted Points |
1RS CIS-PERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 67% | 17% | 65% | 14% |
Total | 40 | 67% | 17% | 65% | 14% |
Miscellaneous Statistics for the Samples |
1RS CIS-PERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 88 |